Impact of Chronic Kidney Disease on Outcomes of Primary PCI

Authors

  • Muhammad Idrees Khan Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
  • Hameed Ullah Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
  • Naveed Ahmad Khan Department of Urology, Institute of Kidney Disease, Peshawar, Pakistan
  • Spogmai Department of Obstetrics and Gynaecology, Hayatabad Medical Complex, Peshawar, Pakistan
  • Sohail Ahmad Department of cardiology, Saidu Teaching Hospital, Swat, Pakistan
  • Muhammad Hafeez Orakzai Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v2i02.159

Keywords:

Chronic Kidney Disease, PCI, MACE, Mortality

Abstract

Objective: To assess the impact of chronic kidney disease (CKD) on outcomes, including major adverse cardiac events (MACE) and mortality, in patients undergoing primary percutaneous coronary intervention (PCI) at the Hayatabad Medical Complex, Peshawar.

Methodology:  A prospective cohort study was conducted from September 2022, to April 2023. A total of 250 patients were enrolled, divided into two groups: 125 patients with CKD (eGFR <60 mL/min/1.73m²) and 125 without CKD (eGFR ≥60 mL/min/1.73m²). Data on demographics, procedural success, MACE, mortality, and follow-up at one and three months were collected. Statistical analysis was performed using Chi-square tests to compare the outcomes between the two groups, with significance set at p < 0.05.

Results:  The CKD group had a significantly higher incidence of MACE (56 vs. 33 events, p = 0.003) and mortality (47 vs. 26 deaths, p = 0.01) compared to the Non-CKD group. Procedural success rates were similar between the groups (44.8% for CKD vs. 55.2% for Non-CKD, p = 0.16). These findings confirm CKD as a critical predictor of poor outcomes in PCI patients.

Conclusion:  CKD significantly increases the risks of MACE and mortality in PCI patients, despite similar procedural success rates. These results highlight the need for targeted management and follow-up strategies for CKD patients undergoing PCI in Pakistan

References

Rubartelli, P., Bruzzone, M., Ariel Sanchez, F., Bologna, E., Iannone, A., & Fedele, M. (2020). Effect of pre-existing chronic kidney disease, anaemia and diabetes mellitus on mid-term mortality in patients with STEMI treated with primary PCI. Eur Heart J [Internet]. Nov 1;41(Supplement_2). https://academic.oup.com/eurheartj/article/doi/10.1093/ehjci/ehaa946.1775/6004408

Hashimoto Y, Ozaki Y, Kan S, Nakao K, Kimura K, Ako J, et al. Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy ― Insights From the J-MINUET Study ―. Circ J [Internet]. 2021 Sep 24;85(10):CJ-20-1115. Available from: https://www.jstage.jst.go.jp/article/circj/85/10/85_CJ-20-1115/_article

Stähli, B. E., Gebhard, C., Gick, M., Ferenc, M., Mashayekhi, K., Buettner, H. J., Neumann, F.-J., & Toma, A. (2017). Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function. Clinical Research in Cardiology, 107(3), 259–267. https://doi.org/10.1007/s00392-017-1179-x

Milojevic, M., Head, S. J., Mack, M. J., Mohr, F. W., Morice, M.-C., Dawkins, K. D., Holmes, D. R., Serruys, P. W., & Kappetein, A. P. (2018). The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial. EuroIntervention, 14(1), 102–111. https://doi.org/10.4244/eij-d-17-00620

Watanabe, Y., Mitomo, S., Naganuma, T., Chieffo, A., Montorfano, M., & Nakamura S. (2021). Impact of Chronic Kidney Disease in Patients With Diabetes Mellitus after Percutaneous Coronary Intervention for Left Main Distal Bifurcation (From the Milan and New–Tokyo (MITO) Registry). Am J Cardiol [Internet]. 33–9. https://linkinghub.elsevier.com/retrieve/pii/S000291492031095X

Cilia, L., Sharbaugh, M., Marroquin, O. C., Toma, C., Smith, C., &Thoma, F. (2019). Impact of Chronic Kidney Disease and Anemia on Outcomes After Percutaneous Coronary Revascularization. Am J Cardiol 124(6), 851–6. https://linkinghub.elsevier.com/retrieve/pii/S0002914919306484

Tajti, P., Karatasakis, A., Danek, B. A., Alaswad, K., Karmpaliotis, D., &Jaffer, F. A. (2018). In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease. J Invasive Cardiol 30(11), 113–21. https://api.semanticscholar.org/CorpusID:52276022

Malik, A. O., Peri-Okonny, P., Grantham, J., Lombardi, W., Karmpaliotis, D., Moses, J. (2019). Impact of chronic kidney disease on clinical and health status outcomes after chronic total occlusion percutaneous coronary intervention. J Am Coll Cardiol, 73(9), 1282. https://linkinghub.elsevier.com/retrieve/pii/S0735109719318893

Siddiqui, A., Bhatti, K. I., Farman, M. T., & Khan, N. U. (2019). FREQUENCY OF RISK FACTORS IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME BELOW 40 YEARS OF AGE. Pakistan Heart Journal, 52(3). https://doi.org/10.47144/phj.v52i3.1785

Downloads

Published

2024-11-04

How to Cite

Khan, M. I., Hameed Ullah, Khan, N. A., Spogmai, Ahmad, S., & Orakzai, M. H. (2024). Impact of Chronic Kidney Disease on Outcomes of Primary PCI. Indus Journal of Bioscience Research, 2(02), 237–243. https://doi.org/10.70749/ijbr.v2i02.159